Skip to main content
SpringerLink
Log in

What’s New in Alternative Therapies for Glaucoma

  • Chapter
  • First Online:
Glaucoma

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

  • 932 Accesses

Abstract

The interest in complementary and alternative treatment modalities for glaucoma has essentially been driven by the subset of patients who continue to progress despite rigorous IOP control. As a result, considerable attention has been directed towards the effects of blood flow, neuroprotection and oxidative stress on glaucoma progression. This chapter reviews what is new in the literature regarding complementary and alternative glaucoma treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wan MJ, Daniel S, Kassam F, et al. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. 2012;21(2):79–82.

    PubMed  Google Scholar 

  2. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun. 1994;201(2):748–55.

    Article  CAS  PubMed  Google Scholar 

  3. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999;15(3):233–40.

    Article  CAS  PubMed  Google Scholar 

  4. Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res. 2004;28(3):153–7.

    Article  CAS  PubMed  Google Scholar 

  5. Eckert A, Keil U, Kressmann S, et al. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry. 2003;36(Suppl 1):S15–23.

    CAS  PubMed  Google Scholar 

  6. Park JW, Kwon HJ, Chung WS, Kim CY, Seong GJ. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma. Korean J Ophthalmol. 2011;25(5):323–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lee J, Sohn SW, Kee C. Effect of Ginkgo biloba extract on visual field progression in normal tension glaucoma. J Glaucoma. 2013;22(9):780–4.

    Article  PubMed  Google Scholar 

  8. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110(2):359–62; discussion 362–54.

    Article  PubMed  Google Scholar 

  9. Guo X, Kong X, Huang R, et al. Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Invest Ophthalmol Vis Sci. 2014;55(1):110–6.

    Article  PubMed  Google Scholar 

  10. Rhee DJ, Katz LJ, Spaeth GL, Myers JS. Complementary and alternative medicine for glaucoma. Surv Ophthalmol. 2001;46(1):43–55.

    Article  CAS  PubMed  Google Scholar 

  11. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med. 1997;336(15):1108.

    Article  CAS  PubMed  Google Scholar 

  12. Matthews MK Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology. 1998;50(6):1933–4.

    Article  PubMed  Google Scholar 

  13. Tan MS, Yu JT, Tan CC, et al. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis. 2015;43(2):589–603.

    Article  CAS  PubMed  Google Scholar 

  14. Mozaffarieh M, Grieshaber MC, Orgul S, Flammer J. The potential value of natural antioxidative treatment in glaucoma. Surv Ophthalmol. 2008;53(5):479–505.

    Article  CAS  PubMed  Google Scholar 

  15. Kang JH, Ivey KL, Boumenna T, Rosner B, Wiggs JL, Pasquale LR. Prospective study of flavonoid intake and risk of primary open-angle glaucoma. Acta Ophthalmol. 2018;96:e692.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Al Owaifeer AM, Al Taisan AA. The role of diet in glaucoma: a review of the current evidence. Ophthalmol Therapy. 2018;7:19.

    Article  Google Scholar 

  17. Jiwani AZ, Rhee DJ, Brauner SC, et al. Effects of caffeinated coffee consumption on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude: a randomized controlled trial. Eye. 2012;26(8):1122–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kang JH, Willett WC, Rosner BA, Hankinson SE, Pasquale LR. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Invest Ophthalmol Vis Sci. 2008;49(5):1924–31.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Pasquale LR, Wiggs JL, Willett WC, Kang JH. The Relationship between caffeine and coffee consumption and exfoliation glaucoma or glaucoma suspect: a prospective study in two cohorts. Invest Ophthalmol Vis Sci. 2012;53(10):6427–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Terai N, Gedenk A, Spoerl E, Pillunat LE, Stodtmeister R. The short-term effect of flavonoid-rich dark chocolate on retinal vessel diameter in glaucoma patients and age-matched controls. Acta Ophthalmol. 2014;92(5):e341–5.

    Article  CAS  PubMed  Google Scholar 

  21. Kang JH, Pasquale LR, Willett W, et al. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003;158(4):337–46.

    Article  PubMed  Google Scholar 

  22. Ramdas WD, Schouten J, Webers CAB. The effect of vitamins on glaucoma: a systematic review and meta-analysis. Nutrients. 2018;10(3):E359.

    Article  PubMed  CAS  Google Scholar 

  23. Jung KI, Kim YC, Park CK. Dietary niacin and open-angle glaucoma: the Korean national health and nutrition examination survey. Nutrients. 2018;10(4):E387.

    Article  PubMed  CAS  Google Scholar 

  24. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2005;(2):CD000269.

    Google Scholar 

  25. Schuettauf F, Rejdak R, Thaler S, et al. Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat. Exp Eye Res. 2006;83(5):1128–34.

    Article  CAS  PubMed  Google Scholar 

  26. Parisi V, Manni G, Colacino G, Bucci MG. Cytidine-5′-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology. 1999;106(6):1126–34.

    Article  CAS  PubMed  Google Scholar 

  27. Parisi V. Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5′-diphosphocholine (citicoline): a study of 8 years of follow-up. Documenta ophthalmologica. Adv Ophthalmol. 2005;110(1):91–102.

    Google Scholar 

  28. Parisi V, Coppola G, Centofanti M, et al. Evidence of the neuroprotective role of citicoline in glaucoma patients. Prog Brain Res. 2008;173:541–54.

    Article  CAS  PubMed  Google Scholar 

  29. Ottobelli L, Manni GL, Centofanti M, Iester M, Allevena F, Rossetti L. Citicoline oral solution in glaucoma: is there a role in slowing disease progression? Ophthalmologica. 2013;229(4):219–26.

    Article  CAS  PubMed  Google Scholar 

  30. Roberti G, Tanga L, Parisi V, Sampalmieri M, Centofanti M, Manni G. A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy. Indian J Ophthalmol. 2014;62(5):549–53.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Novack GD. Cannabinoids for treatment of glaucoma. Curr Opin Ophthalmol. 2016;27(2):146–50.

    Article  PubMed  Google Scholar 

  32. Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998;116(11):1433–7.

    Article  CAS  PubMed  Google Scholar 

  33. Gruber AJ, Pope HG, Hudson JI, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med. 2003;33(8):1415–22.

    Article  CAS  PubMed  Google Scholar 

  34. Sun X, Xu CS, Chadha N, Chen A, Liu J. Marijuana for glaucoma: a recipe for disaster or treatment? Yale J Biol Med. 2015;88(3):265–9.

    PubMed  PubMed Central  Google Scholar 

  35. Cooler P, Gregg JM. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. South Med J. 1977;70(8):951–4.

    Article  CAS  PubMed  Google Scholar 

  36. Newell FW, Stark P, Jay WM, Schanzlin DJ. Nabilone: a pressure-reducing synthetic benzopyran in open-angle glaucoma. Ophthalmology. 1979;86(1):156–60.

    Article  CAS  PubMed  Google Scholar 

  37. Tiedeman JS, Shields MB, Weber PA, et al. Effect of synthetic cannabinoids on elevated intraocular pressure. Ophthalmology. 1981;88(3):270–7.

    Article  CAS  PubMed  Google Scholar 

  38. Jones RT, Benowitz NL, Herning RI. Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol. 1981;21(8–9 Suppl):143s–52s.

    Article  CAS  PubMed  Google Scholar 

  39. Flach AJ. Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma. Trans Am Ophthalmol Soc. 2002;100:215–22; discussion 222–14.

    PubMed  PubMed Central  Google Scholar 

  40. Merritt JC, Perry DD, Russell DN, Jones BF. Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma. J Clin Pharmacol. 1981;21(8-9 Suppl):467s–71s.

    Article  CAS  PubMed  Google Scholar 

  41. Chien FY, Wang RF, Mittag TW, Podos SM. Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys. Arch Ophthalmol. 2003;121(1):87–90.

    Article  CAS  PubMed  Google Scholar 

  42. Jampel H. American glaucoma society position statement: marijuana and the treatment of glaucoma. J Glaucoma. 2010;19(2):75–6.

    Article  PubMed  Google Scholar 

  43. Her JS, Liu PL, Cheng NC, et al. Intraocular pressure-lowering effect of auricular acupressure in patients with glaucoma: a prospective, single-blinded, randomized controlled trial. J Altern Complement Med. 2010;16(11):1177–84.

    Article  PubMed  Google Scholar 

  44. Law SK, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev. 2013;(5):CD006030.

    Google Scholar 

  45. Law SK, Lowe S, Law SM, Giaconi JA, Coleman AL, Caprioli J. Prospective evaluation of acupuncture as treatment for glaucoma. Am J Ophthalmol. 2015;160(2):256–65.

    Article  PubMed  Google Scholar 

  46. Kaluza G, Strempel I. Effects of self-relaxation methods and visual imagery on IOP in patients with open-angle glaucoma. Ophthalmologica. 1995;209(3):122–8.

    Article  CAS  PubMed  Google Scholar 

  47. Kaluza G, Strempel I, Maurer H. Stress reactivity of intraocular pressure after relaxation training in open-angle glaucoma patients. J Behav Med. 1996;19(6):587–98.

    Article  CAS  PubMed  Google Scholar 

  48. Zhu MM, Lai JSM, Choy BNK, et al. Physical exercise and glaucoma: a review on the roles of physical exercise on intraocular pressure control, ocular blood flow regulation, neuroprotection and glaucoma-related mental health. Acta Ophthalmol. 2018;96:e676.

    Article  PubMed  Google Scholar 

  49. Yang Y, Li Z, Wang N, et al. Intraocular pressure fluctuation in patients with primary open-angle glaucoma combined with high myopia. J Glaucoma. 2014;23(1):19–22.

    Article  PubMed  Google Scholar 

  50. Jasien JV, Jonas JB, de Moraes CG, Ritch R. Intraocular pressure rise in subjects with and without glaucoma during four common yoga positions. PLoS One. 2015;10(12):e0144505.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Bakke EF, Hisdal J, Semb SO. Intraocular pressure increases in parallel with systemic blood pressure during isometric exercise. Invest Ophthalmol Vis Sci. 2009;50(2):760–4.

    Article  PubMed  Google Scholar 

  52. Vieira GM, Oliveira HB, de Andrade DT, Bottaro M, Ritch R. Intraocular pressure variation during weight lifting. Arch Ophthalmol. 2006;124(9):1251–4.

    Article  PubMed  Google Scholar 

  53. Lasta M, Polak K, Luksch A, Garhofer G, Schmetterer L. Effect of NO synthase inhibition on retinal vessel reaction to isometric exercise in healthy humans. Acta Ophthalmol. 2012;90(4):362–8.

    Article  PubMed  Google Scholar 

  54. Morgan WH, Cunneen TS, Balaratnasingam C, Yu DY. Wearing swimming goggles can elevate intraocular pressure. Br J Ophthalmol. 2008;92(9):1218–21.

    Article  CAS  PubMed  Google Scholar 

  55. Paula AP, Paula JS, Silva MJ, Rocha EM, De Moraes CG, Rodrigues ML. Effects of swimming goggles wearing on intraocular pressure, ocular perfusion pressure, and ocular pulse amplitude. J Glaucoma. 2016;25(10):860–4.

    Article  PubMed  Google Scholar 

  56. Levin LA. Models of neural injury. J Glaucoma. 2001;10(5 Suppl 1):S19–21.

    Article  CAS  PubMed  Google Scholar 

  57. Morimoto T, Miyoshi T, Matsuda S, Tano Y, Fujikado T, Fukuda Y. Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest Ophthalmol Vis Sci. 2005;46(6):2147–55.

    Article  PubMed  Google Scholar 

  58. Al-Majed AA, Brushart TM, Gordon T. Electrical stimulation accelerates and increases expression of BDNF and trkB mRNA in regenerating rat femoral motoneurons. Eur J Neurosci. 2000;12(12):4381–90.

    CAS  PubMed  Google Scholar 

  59. Fujikado T, Morimoto T, Matsushita K, Shimojo H, Okawa Y, Tano Y. Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn J Ophthalmol. 2006;50(3):266–73.

    Article  PubMed  Google Scholar 

  60. Inomata K, Shinoda K, Ohde H, et al. Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol. 2007;245(12):1773–80.

    Article  PubMed  Google Scholar 

  61. Schatz A, Pach J, Gosheva M, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled follow-up study over 1 year. Invest Ophthalmol Vis Sci. 2017;58(1):257–69.

    Article  PubMed  Google Scholar 

  62. Ota Y, Ozeki N, Yuki K, et al. The efficacy of transcorneal electrical stimulation for the treatment of primary open-angle glaucoma: a pilot study. Keio J Med. 2018;67:45.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glaucoma Service, Wills Eye Hospital, Philadelphia, PA, USA

    Alicia Menezes & M. Reza Razeghinejad

Authors
  1. Alicia Menezes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Reza Razeghinejad
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India

    Parul Ichhpujani

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Menezes, A., Razeghinejad, M.R. (2019). What’s New in Alternative Therapies for Glaucoma. In: Ichhpujani, P. (eds) Glaucoma. Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-8457-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-8457-8_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-8456-1

  • Online ISBN: 978-981-13-8457-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation